# Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions

> **NCT00834977** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Amlodipine-benazepril 10 mg-20 mg capsules
- **DRUG:** Lotrel® 10 mg-20 mg capsule

## Key facts

- **NCT ID:** NCT00834977
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2004-05
- **Final completion:** 2004-05
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00834977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00834977, "Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00834977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*